Discontinued — last reported Q4 '22
Business Segments · Other Assets
Total allocated to reportable segments — Other Assets
Boston Scientific Total allocated to reportable segments — Other Assets increased by 16.8% to $7.71B in Q4 2022 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2022
Rolls up toOther Assets
How to read this metric
An increase suggests higher capital intensity or investment in specific business segments, while a decrease may indicate asset divestment, depreciation, or a shift in capital allocation strategy.
Detailed definition
This metric represents the aggregate value of assets specifically assigned to the company's reportable business segments...
Peer comparison
Peers in the medical device industry report similar segment-level asset allocations, though definitions vary based on how companies define their internal reporting structures and asset management policies.
Metric ID:
bsx_segment_total_allocated_to_reportable_segments_other_assetsHistorical Data
2 periods
| Q4 '21 | Q4 '22 | |
|---|---|---|
| Value | $6.60B | $7.71B |
| QoQ Change | — | +16.8% |
| YoY Change | — | +16.8% |
Range$6.60B – $7.71B
Avg YoY Growth+16.8%
Median YoY Growth+16.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's total allocated to reportable segments — other assets?
- Boston Scientific (BSX) reported total allocated to reportable segments — other assets of $7.71B in Q4 2022.
- What does total allocated to reportable segments — other assets mean?
- The total value of assets assigned to specific business segments that are not classified under the company's main operational asset categories.